Xeris Biopharma Up Over 27%, on Track for Highest Close Since February 2019 -- Data Talk

Xeris Biopharma Holdings, Inc. (XERS) is currently at $13.33, up $2.87 or 27.44%

--Would be highest close since Feb. 11, 2019, when it closed at $14.70

--On pace for largest percent increase since May 16, 2022, when it rose 29.24%

--Currently up three consecutive days; up 31.07% over this period

--Best three day stretch since the three days ending Aug. 11, 2025, when it rose 31.15%

--Up 69.81% year-to-date

--Down 51.05% from its all-time closing high of $27.23 on Sept. 10, 2018

--Up 72.89% from 52 weeks ago (Nov. 6, 2025), when it closed at $7.71

--Would be a new 52-week closing high

--Up 151.98% from its 52-week closing low of $5.29 on March 24, 2026

--Traded as high as $13.74; highest intraday level since Feb. 11, 2019, when it hit $15.00

--Up 31.36% at today's intraday high; largest intraday percent increase since May 16, 2022, when it rose as much as 32.75%

All data as of 11:00:46 AM ET

Source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

November 05, 2026 11:02 ET (16:02 GMT)